(Q37923679)

25 August 2017

3 references

25 April 2019

21 November 2020

8 October 2022

Emotional dysfunction in Parkinson's disease (English)

1 reference

25 August 2017

2 references

25 April 2019

21 November 2020

2 references

25 April 2019

21 November 2020

1 reference

21 November 2020

Lee X Blonder

1

1 reference

25 August 2017

John T Slevin

series ordinal

2

1 reference

25 August 2017

1 January 2011

1 reference

25 August 2017

Behavioural Neurology

4 references

25 August 2017

25 April 2019

21 November 2020

8 October 2022

24

1 reference

25 August 2017

3

1 reference

25 August 2017

201-217

1 reference

Creative Commons Attribution 3.0 Unported

25 August 2017

3 references

25 April 2019

21 November 2020

on focus list of Wikimedia project

8 October 2022

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Parkinson's disease-like midbrain sonography abnormalities are frequent in depressive disorders

1 reference

12 December 2020

Depression associated with Parkinson's disease: clinical features and treatment

1 reference

12 December 2020

Relationship between self-reported apathy and executive dysfunction in nondemented patients with Parkinson disease

1 reference

12 December 2020

Validity of the 30-item geriatric depression scale in patients with Parkinson's disease

1 reference

12 December 2020

Parkinson's disease and anxiety: comorbidity with depression

1 reference

12 December 2020

Efficacy and safety of brofaromine in depression: a Canadian multicenter placebo controlled trial and a review of comparative controlled studies

1 reference

12 December 2020

Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease

1 reference

12 December 2020

Prevalence and treatment of depression in Parkinson's disease

1 reference

12 December 2020

Depression in Parkinson's disease: brainstem midline alteration on transcranial sonography and magnetic resonance imaging

1 reference

12 December 2020

Reduced hippocampal volumes associated with the long variant of the serotonin transporter polymorphism in major depression

1 reference

12 December 2020

Anxiety disorders in patients with Parkinson's disease

1 reference

12 December 2020

Effects of the dopamine agonist pramipexole on depression, anhedonia and motor functioning in Parkinson's disease

1 reference

12 December 2020

Depression in Parkinson's disease: a quantitative and qualitative analysis

1 reference

12 December 2020

Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies

1 reference

12 December 2020

Chronic sorrow in persons with Parkinson's and their spouses

1 reference

12 December 2020

Apathy in Parkinson's disease.

1 reference

12 December 2020

The catecholamine hypothesis of affective disorders: a review of supporting evidence

1 reference

12 December 2020

Depression in veterans with Parkinson's disease: frequency, co-morbidity, and healthcare utilization

1 reference

12 December 2020

Allelic variation of serotonin transporter expression is associated with depression in Parkinson's disease.

1 reference

12 December 2020

The influence of depression on cognition in Parkinson's disease: a pattern of impairment distinguishable from Alzheimer's disease.

1 reference

12 December 2020

The nosological position of apathy in clinical practice

1 reference

12 December 2020

Basal ganglia functional connectivity based on a meta-analysis of 126 positron emission tomography and functional magnetic resonance imaging publications.

1 reference

12 December 2020

Magnetic resonance imaging of the caudate nuclei in depression. Preliminary observations

1 reference

12 December 2020

Increased risk of Parkinson's disease after depression: a retrospective cohort study

1 reference

12 December 2020

The neural system that bridges reward and cognition in humans: an fMRI study

1 reference

12 December 2020

Evidence for atypical depression in Parkinson's disease

1 reference

12 December 2020

Reliability and validity of the Beck depression inventory in patients with Parkinson's disease

1 reference

12 December 2020

Brain morphometric abnormalities in geriatric depression: long-term neurobiological effects of illness duration

1 reference

12 December 2020

Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity

1 reference

12 December 2020

Apathy is not depression

1 reference

12 December 2020

Depression in Parkinson's disease. Diffusion tensor imaging study

1 reference

12 December 2020

Recognizing depression in patients with Parkinson's disease: accuracy and specificity of two depression rating scale

1 reference

12 December 2020

1 reference

12 December 2020

How common are the "common" neurologic disorders?

1 reference

12 December 2020

A systematic review of prevalence studies of depression in Parkinson's disease

1 reference

12 December 2020

An inventory for measuring clinical anxiety: psychometric properties

1 reference

12 December 2020

Mirtazapine enhances frontocortical dopaminergic and corticolimbic adrenergic, but not serotonergic, transmission by blockade of alpha2-adrenergic and serotonin2C receptors: a comparison with citalopram

1 reference

12 December 2020

Mental depression in hypertensive patients treated for long periods with large doses of reserpine.

1 reference

12 December 2020

Depression in Parkinson's disease: convergence from voxel-based morphometry and functional magnetic resonance imaging in the limbic thalamus

1 reference

12 December 2020

Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission

1 reference

12 December 2020

Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease

1 reference

12 December 2020

Prevalence of anxiety disorders and anxiety subtypes in patients with Parkinson's disease

1 reference

12 December 2020

Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial

1 reference

12 December 2020

Cortico-motor excitability of the lower limb motor representation: a comparative study in Parkinson's disease and healthy controls

1 reference

12 December 2020

Antidepressant studies in Parkinson's disease: a review and meta-analysis

1 reference

12 December 2020

Pramipexole in routine clinical practice: a prospective observational trial in Parkinson's disease

1 reference

12 December 2020

Widespread origin of the primate mesofrontal dopamine system

1 reference

12 December 2020

The effects of right and left hemiparkinsonism on prosody

1 reference

12 December 2020

Nonmotor fluctuations in Parkinson's disease: frequent and disabling

1 reference

12 December 2020

Alterations in catecholamine neurons of the locus coeruleus in senile dementia of the Alzheimer type and in Parkinson's disease with and without dementia and depression.

1 reference

12 December 2020

The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson's disease

1 reference

12 December 2020

Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's disease

1 reference

12 December 2020

Pramipexole versus sertraline in the treatment of depression in Parkinson's disease: a national multicenter parallel-group randomized study

1 reference

12 December 2020

Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease

1 reference

12 December 2020

In vivo evidence for the involvement of dopamine-D2 receptors in striatum and anterior cingulate gyrus in major depression

1 reference

12 December 2020

Enlargement of the amygdala in patients with a first episode of major depression

1 reference

12 December 2020

Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPaMiP study

1 reference

12 December 2020

The association between motor subtypes and psychopathology in Parkinson's disease

1 reference

12 December 2020

Uncovering the hidden placebo effect in deep-brain stimulation for Parkinson's disease

1 reference

12 December 2020

The dopamine D3 receptor and drug dependence: effects on reward or beyond?

1 reference

12 December 2020

Pathological gambling caused by drugs used to treat Parkinson disease

1 reference

12 December 2020

Increased risk of developing Parkinson's disease for patients with major affective disorder: a register study

1 reference

12 December 2020

Depression in Parkinson's disease. A positron emission study

1 reference

12 December 2020

Serotonin and dopamine transporter genes do not influence depression in Parkinson's disease

1 reference

12 December 2020

Reliability and validity of the Geriatric Depression Scale in depression in Parkinson's disease

1 reference

12 December 2020

Apathy and depression in Parkinson disease

1 reference

12 December 2020

Levodopa challenge neuroimaging of levodopa-related mood fluctuations in Parkinson's disease

1 reference

12 December 2020

In vivo evidence for differential association of striatal dopamine and midbrain serotonin systems with neuropsychiatric symptoms in Parkinson's disease

1 reference

12 December 2020

The role of dopamine in reward and pleasure behaviour--review of data from preclinical research

1 reference

12 December 2020

Parkinsonian patients report blunted subjective effects of methylphenidate

1 reference

12 December 2020

Serotonin-dopamine interaction as a focus of novel antidepressant drugs

1 reference

12 December 2020

The human orbitofrontal cortex: linking reward to hedonic experience

1 reference

12 December 2020

SSRIs in the treatment of depression in Parkinson's disease

1 reference

12 December 2020

Comparison of pramipexole, fluoxetine, and placebo in patients with major depression

1 reference

12 December 2020

Validity of Hamilton Depression Inventory in Parkinson's disease

1 reference

12 December 2020

Prozac (fluoxetine, Lilly 110140), the first selective serotonin uptake inhibitor and an antidepressant drug: twenty years since its first publication

1 reference

12 December 2020

Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system

1 reference

12 December 2020

Sustained administration of pramipexole modifies the spontaneous firing of dopamine, norepinephrine, and serotonin neurons in the rat brain

1 reference

12 December 2020

[Non-motor fluctuations in Parkinson's disease]

1 reference

12 December 2020

Modulation of dopamine release by striatal 5-HT2C receptors

1 reference

12 December 2020

The discovery of antidepressants: a winding path

1 reference

12 December 2020

Anxiety rating scales in Parkinson's disease: critique and recommendations

1 reference

12 December 2020

The Association of Ventral Tegmental Area Histopathology With Adult Dementia

1 reference

12 December 2020

Depression and anxiety in Parkinson's disease: possible effect of genetic variation in the serotonin transporter

1 reference

12 December 2020

The accuracy of diagnosis of major depression in patients with Parkinson's disease: a comparative study among the UPDRS, the geriatric depression scale and the Beck depression inventory.

1 reference

12 December 2020

Depressed mood and executive dysfunction in early Parkinson's disease

1 reference

12 December 2020

Pathophysiology of the basal ganglia in Parkinson's disease.

1 reference

12 December 2020

Dose-response relationship of levodopa with mood and anxiety in fluctuating Parkinson's disease: a double-blind, placebo-controlled study.

1 reference

12 December 2020

Reduced hippocampal volume in unmedicated, remitted patients with major depression versus control subjects

1 reference

12 December 2020

Major depressive disorder in Parkinson's disease: a register-based study

1 reference

12 December 2020

1 reference

12 December 2020

Changes of brain morphometry in first-episode, drug-naïve, non-late-life adult patients with major depression: an optimized voxel-based morphometry study.

1 reference

12 December 2020

Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study.

1 reference

12 December 2020

Clinico-pathological correlations in Parkinson's disease

1 reference

12 December 2020

Degeneration of substantia nigra in chronic Parkinson's disease visualized by transcranial color-coded real-time sonography

1 reference

12 December 2020

Morphometric changes of gray matter in Parkinson's disease with depression: a voxel-based morphometry study

1 reference

12 December 2020

Dopaminergic modulation of cortical function in patients with Parkinson's disease

1 reference

12 December 2020

Remarkable effect of milnacipran, a serotonin-noradrenalin reuptake inhibitor (SNRI), on depressive symptoms in patients with Parkinson's disease who have insufficient response to selective serotonin reuptake inhibitors (SSRIs): two case reports

1 reference

12 December 2020

Hippocampal changes in patients with a first episode of major depression

1 reference

12 December 2020

Neural substrates of facial emotion processing using fMRI.

1 reference

12 December 2020

Increased risk of depressive and anxiety disorders in relatives of patients with Parkinson disease

1 reference

12 December 2020

Validity of the Cornell scale for depression in dementia in Parkinson's disease with and without cognitive impairment.

1 reference

12 December 2020

A critical evaluation of the Braak staging scheme for Parkinson's disease.

1 reference

12 December 2020

Cerebral and cerebellar gray matter reduction in first-episode patients with major depressive disorder: a voxel-based morphometry study

1 reference

12 December 2020

Occurrence and risk factors for apathy in Parkinson disease: a 4-year prospective longitudinal study

1 reference

12 December 2020

The syndromal validity and nosological position of apathy in Parkinson's disease.

1 reference

12 December 2020

Comparison of desipramine and citalopram treatments for depression in Parkinson's disease: a double-blind, randomized, placebo-controlled study

1 reference

12 December 2020

Hippocampal volume reduction in major depression.

1 reference

12 December 2020

Higher incidence of depression preceding the onset of Parkinson's disease: a register study

1 reference

12 December 2020

The role of the brain reward system in depression

1 reference

12 December 2020

Selective serotonin reuptake inhibitors: a review of efficacy and tolerability in depression

1 reference

12 December 2020

Depression and Parkinson's disease: a review

1 reference

12 December 2020

1 reference

12 December 2020

The patients' perspective: Results of a survey assessing knowledge about and attitudes toward depression in PD

1 reference

12 December 2020

Functional specialization within rostral prefrontal cortex (area 10): a meta-analysis

1 reference

12 December 2020

D3 dopamine receptor mRNA is widely expressed in the human brain

1 reference

12 December 2020

Plasma HVA and anxiety in patients with panic disorder.

1 reference

12 December 2020

The cerebellar cognitive affective syndrome

1 reference

12 December 2020

Transcranial sonography for diagnosis of Parkinson's disease

1 reference

12 December 2020

A controlled trial of antidepressants in patients with Parkinson disease and depression

1 reference

12 December 2020

Serotonin-dopamine interaction: electrophysiological evidence

1 reference

12 December 2020

Depression and disability in Parkinson's disease.

1 reference

12 December 2020

Neuropsychological impairment in Parkinson's disease with and without depression

1 reference

12 December 2020

Functional neuroanatomical substrates of altered reward processing in major depressive disorder revealed by a dopaminergic probe

1 reference

12 December 2020

Reliability, validity, and clinical correlates of apathy in Parkinson's disease

1 reference

12 December 2020

Effect of age on geriatric depression scale performance in Parkinson's disease

1 reference

12 December 2020

Transcranial sonography in movement disorders

1 reference

12 December 2020

Depression rating scales in Parkinson's disease: critique and recommendations

1 reference

12 December 2020

Dopamine D2-like receptors and the antidepressant response

1 reference

12 December 2020

Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents

1 reference

12 December 2020

A clinico-pathological study of subtypes in Parkinson's disease

1 reference

12 December 2020

Psychiatric comorbidity in a population of Parkinson's disease patients

1 reference

12 December 2020

Anhedonia, depression, and motor functioning in Parkinson's disease during treatment with pramipexole

1 reference

12 December 2020

Anxiety disorders in Parkinson's disease: prevalence and risk factors

1 reference

12 December 2020

Differential response patterns in the striatum and orbitofrontal cortex to financial reward in humans: a parametric functional magnetic resonance imaging study

1 reference

12 December 2020

Cognitive impairments in early Parkinson's disease are accompanied by reductions in activity in frontostriatal neural circuitry.

1 reference

12 December 2020

Prevalence, clinical manifestations, etiology, and treatment of depression in Parkinson's disease

1 reference

12 December 2020

A validation study of depressive syndromes in Parkinson's disease

1 reference

12 December 2020

Abnormal basal ganglia outflow in Parkinson's disease identified with PET. Implications for higher cortical functions

1 reference

12 December 2020

Major and minor depression in Parkinson's disease: a neuropsychological investigation.

1 reference

12 December 2020

Parallel Organization of Functionally Segregated Circuits Linking Basal Ganglia and Cortex

1 reference

12 December 2020

Levodopa dependence and abuse in Parkinson's disease.

1 reference

12 December 2020

Staging of brain pathology related to sporadic Parkinson's disease

1 reference

12 December 2020

Depression predicts the pattern of cognitive impairment in early Parkinson's disease.

1 reference

12 December 2020

Functional connectivity of human striatum: a resting state FMRI study

1 reference

12 December 2020

Indoleamines and affective disorders

1 reference

12 December 2020

Decreased regional homogeneity in insula and cerebellum: a resting-state fMRI study in patients with major depression and subjects at high risk for major depression

1 reference

12 December 2020

Recognition and treatment of depression in Parkinson's disease

1 reference

12 December 2020

1 reference

12 December 2020

1 reference

12 December 2020

The correlation of depression with functional activity in Parkinson's disease

1 reference

12 December 2020

Major depression, 5HTTLPR genotype, suicide and antidepressant influences on thalamic volume

1 reference

12 December 2020

Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations

1 reference

12 December 2020

Selective hypometabolism in the inferior frontal lobe in depressed patients with Parkinson's disease

1 reference

12 December 2020

Cognitive functions in major depression and Parkinson disease

1 reference

12 December 2020

Regional patterns of brain tissue loss associated with depression in Parkinson disease

1 reference

12 December 2020

The neuropathological basis for depression in Parkinson's disease

1 reference

12 December 2020

The occurrence of depression in Parkinson's disease. A community-based study.

1 reference

12 December 2020

Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease

1 reference

12 December 2020

Neurochemistry of Parkinson's disease: relation between striatal and limbic dopamine

1 reference

12 December 2020

Provisional diagnostic criteria for depression in Parkinson's disease: report of an NINDS/NIMH Work Group

1 reference

12 December 2020

Depression, intellectual impairment, and Parkinson disease.

1 reference

12 December 2020

Identifiers

DOI

10.1155/2011/143857

1 reference

release_ogvdzmbt4bfyvbnod3yvqih464

25 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ogvdzmbt4bfyvbnod3yvqih464

24 November 2022

mapped directly with Wikidata item

1 reference

25 August 2017

PubMed publication ID

21876260

1 reference